Evidence map›Paper›PMID 41440624›Full record

ArticleJournal of functional biomaterials2025

Biomimetic Glycosaminoglycan-Enriched Electrospun Polymeric Scaffolds for Enhanced Early Tissue Regeneration.

Morgane Meyer, Rana Smaida, Henri Favreau, Cristina Yus, Hervé Gegout, Manuel Arruebo, Nadia Bahlouli, Guy Ladam, Guillaume Conzatti, Stephan Lemmens and 3 more

Abstract read
In one paragraph

Article in Journal of functional biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Morgane MeyerInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
Rana SmaidaInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
Henri FavreauInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
Cristina YusInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0002-1505-498X
Hervé GegoutInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
Manuel ArrueboInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0003-3165-0156
Nadia BahlouliUniversité de Strasbourg, Faculté de Chirurgie Dentaire, Faculté de Médecine, Faculté de Pharmacie, 4 Rue Blaise Pascal, 67000 Strasbourg, France.ORCID 0000-0003-4404-5190
Guy LadamPBS (UMR 6270), CNRS, INSA Rouen, UNIROUEN, Normandy University, 55 rue Saint-Germain, 27000 Évreux, France.ORCID 0000-0001-5774-106X
Guillaume ConzattiInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.ORCID 0000-0002-8002-5894
Stephan LemmensLamina Therapeutics, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
Guoqiang HuaInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.
Florence FiorettiInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.ORCID 0000-0002-2433-5070
Nadia Benkirane-JesselInstitut National de la Santé et de la Recherche Médicale (INSERM) UMR1260, Nanomédicine Régénérative, 1 Rue Eugène Boeckel, 67000 Strasbourg, France.

Funding

Agence Nationale de la Recherche ANR-19-CE17-0032Lamina Therapeutics PhD 2023-2026
6 · The paper itself

Abstract

Implantable scaffolds are increasingly recognized as transformative tools in regenerative medicine, offering the potential to prevent or mitigate tissue degeneration. Osteoarthritis is a widespread degenerative joint disease that often progresses from early focal lesions to severe joint damage, creating substantial clinical and socioeconomic burdens. Preventive strategies for early-stage lesions remain limited. This study reports the design and development of a functional polymeric scaffold intended to support early tissue regeneration and potentially prevent lesion progression. The scaffold consists of an electrospun poly (ε-caprolactone) nanofibrous membrane enriched with glycosaminoglycans, including hyaluronic acid and chondroitin sulfate, to mimic essential features of the cartilage extracellular matrix and provide a supportive microenvironment. Complete structural, physicochemical, and mechanical characterization was performed to assess the scaffold architecture, stability, hydration properties, and suitability for tissue environments. In vitro investigations were conducted to evaluate cytocompatibility and the interaction of the scaffold with relevant cell types. The scaffold is designed as a potential future preventive strategy to support cartilage integrity and limit disease progression. This approach represents a promising strategy to preserve joint integrity and function, addressing a critical unmet clinical need and enabling translation toward clinical application.

Indexed as

cartilagecell recruitmentelectrospun scaffoldfunctional polymeric biomaterialglycosaminoglycans

Identifiers

PMID41440624
PMCPMC12733769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.